BSE NSE
Your Result on : Company News Details
Aarti Pharmalabs Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543748
ISIN Demat
INE0LRU01027
Book Value (Rs)
203.4396162
NSE Symbol
AARTIPHARM
Divident Yield %
0.56
Market Cap
(Rs In Cr.)
8,086
P/E (TTM)
31.42
EPS (TTM)
28.39
Face Value
(Rs)
5
Back
Aarti Pharmalabs consolidated net profit rises 35.39% in the March 2025 quarter
12-May-25   Hrs IST

Net profit of Aarti Pharmalabs rose 35.39% to Rs 88.34 crore in the quarter ended March 2025 as against Rs 65.25 crore during the previous quarter ended March 2024. Sales rose 11.47% to Rs 563.78 crore in the quarter ended March 2025 as against Rs 505.77 crore during the previous quarter ended March 2024.

For the full year,net profit rose 25.59% to Rs 272.40 crore in the year ended March 2025 as against Rs 216.90 crore during the previous year ended March 2024. Sales rose 14.17% to Rs 2115.07 crore in the year ended March 2025 as against Rs 1852.61 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales563.78505.77 11 2115.071852.61 14
OPM %25.8323.24 -21.9620.84 -
PBDT137.44114.87 20 447.59373.73 20
PBT114.6295.75 20 360.69300.49 20
NP88.3465.25 35 272.40216.90 26

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)